• Consensus Rating: Hold
  • Consensus Price Target: $2.30
  • Forecasted Upside: 27.07%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$1.81
+0 (0.00%)

This chart shows the closing price for OLPX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Olaplex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OLPX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OLPX

Analyst Price Target is $2.30
▲ +27.07% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Olaplex in the last 3 months. The average price target is $2.30, with a high forecast of $3.00 and a low forecast of $1.50. The average price target represents a 27.07% upside from the last price of $1.81.

This chart shows the closing price for OLPX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 5 investment analysts is to hold stock in Olaplex. This rating has held steady since February 2024, when it changed from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 3 sell ratings
6/29/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 8 hold ratings
  • 4 sell ratings
9/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 2 sell ratings
12/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 0 sell ratings
3/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 0 sell ratings
6/23/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
9/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/20/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/11/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$2.00 ➝ $1.50
11/7/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$3.00 ➝ $3.00
10/31/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$3.00 ➝ $3.00
8/7/2024TD CowenBoost TargetHold ➝ Hold$1.80 ➝ $2.00
8/6/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$2.00 ➝ $2.00
7/31/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$2.00 ➝ $2.00
7/12/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$2.00 ➝ $2.00
5/2/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$2.00 ➝ $2.00
4/26/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$2.00 ➝ $2.00
4/5/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$2.00
3/19/2024Piper SandlerUpgradeUnderweight ➝ Neutral$1.25 ➝ $2.00
3/4/2024Truist FinancialLower TargetBuy ➝ Buy$7.00 ➝ $3.00
2/29/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$2.00
2/22/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$2.00
11/21/2023Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$2.00
11/9/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$3.65 ➝ $2.10
11/8/2023Telsey Advisory GroupLower TargetMarket Perform ➝ Market Perform$4.00 ➝ $2.00
10/31/2023Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$4.00
10/13/2023Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$4.00
10/4/2023BarclaysUpgradeUnderweight ➝ Equal Weight$2.00
8/25/2023Piper SandlerDowngradeNeutral ➝ Underweight$3.00 ➝ $2.00
8/11/2023Canaccord Genuity GroupReiterated RatingBuy ➝ Hold$5.00 ➝ $3.00
8/11/2023Canaccord Genuity GroupDowngradeBuy ➝ Hold$5.00 ➝ $3.00
8/10/2023BarclaysLower TargetUnderweight ➝ Underweight$3.00 ➝ $2.00
8/9/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$4.00 ➝ $3.65
8/9/2023The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$6.00 ➝ $3.00
8/9/2023Truist FinancialLower Target$15.00 ➝ $7.00
8/9/2023Telsey Advisory GroupDowngradeOutperform ➝ Market Perform$6.00 ➝ $4.00
8/1/2023Telsey Advisory GroupReiterated RatingOutperform ➝ Outperform$6.00
5/10/2023Bank of AmericaLower Target$4.00 ➝ $3.25
3/16/2023Piper SandlerLower Target$5.00 ➝ $4.00
3/16/2023TD CowenDowngradeOutperform ➝ Market Perform$10.00 ➝ $4.50
3/7/2023Morgan StanleyLower TargetEqual Weight$6.00 ➝ $5.50
3/3/2023Truist FinancialBoost Target$10.00 ➝ $15.00
3/1/2023Telsey Advisory GroupLower TargetOutperform$9.00 ➝ $7.00
2/28/2023The Goldman Sachs GroupDowngradeBuy ➝ Neutral$6.00
2/22/2023Telsey Advisory GroupLower TargetOutperform$11.00 ➝ $9.00
1/13/2023JPMorgan Chase & Co.Boost TargetUnderweight$7.00 ➝ $8.00
11/17/2022Canaccord Genuity GroupInitiated CoverageBuy$8.00
11/16/2022Canaccord Genuity GroupInitiated CoverageBuy
11/10/2022Morgan StanleyLower TargetEqual Weight$6.50 ➝ $6.00
10/19/2022CowenLower TargetOutperform$22.00 ➝ $10.00
10/19/2022Telsey Advisory GroupLower TargetOutperform$25.00 ➝ $11.00
10/19/2022BarclaysDowngradeEqual Weight ➝ Underweight$5.00
10/19/2022Truist FinancialLower TargetBuy$25.00 ➝ $10.00
10/19/2022CowenLower TargetOutperform$22.00 ➝ $10.00
10/19/2022Raymond JamesDowngradeStrong-Buy ➝ Market Perform$20.00 ➝ $15.00
10/19/2022Piper SandlerLower TargetNeutral$12.00 ➝ $8.00
10/19/2022Bank of AmericaDowngradeBuy ➝ Underperform$15.00 ➝ $5.00
10/19/2022JPMorgan Chase & Co.DowngradeOverweight ➝ Underweight$16.00 ➝ $8.00
10/19/2022Jefferies Financial GroupDowngradeBuy ➝ Hold$18.00 ➝ $6.00
10/19/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$13.00 ➝ $6.50
10/13/2022JPMorgan Chase & Co.Lower TargetOverweight$19.00 ➝ $16.00
10/10/2022The Goldman Sachs GroupLower TargetBuy$22.00 ➝ $17.00
10/4/2022Morgan StanleyLower TargetOverweight$17.50 ➝ $16.00
9/29/2022Piper SandlerDowngradeOverweight ➝ Neutral$19.00 ➝ $12.00
9/7/2022Piper SandlerLower TargetOverweight$21.00 ➝ $19.00
8/12/2022Morgan StanleyLower TargetOverweight$19.00 ➝ $17.50
8/11/2022BarclaysLower TargetEqual Weight$16.00 ➝ $15.00
8/10/2022The Goldman Sachs GroupLower TargetBuy$26.00 ➝ $22.00
8/10/2022Piper SandlerLower TargetOverweight$24.00 ➝ $21.00
8/3/2022BarclaysDowngradeOverweight ➝ Equal Weight$17.00 ➝ $16.00
7/21/2022JPMorgan Chase & Co.Lower Target$23.00 ➝ $21.00
6/16/2022Piper SandlerLower TargetOverweight$26.00 ➝ $24.00
5/12/2022CowenLower Target$33.00 ➝ $22.00
5/12/2022CowenLower Target$33.00 ➝ $22.00
4/19/2022Piper SandlerLower TargetOverweight$36.00 ➝ $30.00
4/18/2022Raymond JamesLower TargetStrong-Buy$28.00 ➝ $24.00
4/14/2022JPMorgan Chase & Co.Boost Target$23.00 ➝ $24.00
3/10/2022Morgan StanleyLower TargetOverweight$34.00 ➝ $31.00
3/9/2022Raymond JamesLower TargetStrong-Buy$37.00 ➝ $28.00
3/9/2022BarclaysUpgradeEqual Weight ➝ Overweight$29.00 ➝ $17.00
2/23/2022Jefferies Financial GroupUpgradeHold ➝ Buy$25.00
11/8/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$31.00
10/25/2021Raymond JamesInitiated CoverageStrong-Buy
10/25/2021Evercore ISIInitiated CoverageOutperform$50.00
10/25/2021Telsey Advisory GroupReiterated RatingOutperform$34.00
10/25/2021BarclaysInitiated CoverageEqual Weight$32.00
10/25/2021Morgan StanleyInitiated CoverageEqual Weight$31.00
10/25/2021Truist FinancialInitiated CoverageBuy$35.00
10/25/2021JPMorgan Chase & Co.Initiated CoverageOverweight$32.00
10/25/2021Jefferies Financial GroupInitiated CoverageHold$30.00
10/25/2021CowenInitiated CoverageOutperform$33.00
10/25/2021Piper SandlerInitiated CoverageOverweight$34.00
10/25/2021Bank of AmericaInitiated CoverageBuy$37.00
10/25/2021The Goldman Sachs GroupInitiated CoverageBuy$34.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

1.46 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/25/2024
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2024
  • 4 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/24/2024
  • 11 very positive mentions
  • 25 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/23/2024
  • 7 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/22/2024
  • 7 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/22/2024
  • 7 very positive mentions
  • 15 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
11/21/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/21/2024

Current Sentiment

  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Olaplex logo
Olaplex Holdings, Inc. develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers. The company distributes its products through professional distributors in salons, directly to retailers for sale in their physical stores, e-commerce sites, and its website, Olaplex.com, as well as third party e-commerce platforms. The company was founded in 2014 and is based in Santa Barbara, California.
Read More

Today's Range

Now: $1.81
Low: $1.76
High: $1.88

50 Day Range

MA: $1.98
Low: $1.62
High: $2.29

52 Week Range

Now: $1.81
Low: $1.19
High: $2.98

Volume

1,971,525 shs

Average Volume

2,381,232 shs

Market Capitalization

$1.20 billion

P/E Ratio

30.17

Dividend Yield

N/A

Beta

2.48

Frequently Asked Questions

What sell-side analysts currently cover shares of Olaplex?

The following Wall Street sell-side analysts have issued stock ratings on Olaplex in the last year: Barclays PLC, Piper Sandler, TD Cowen, Telsey Advisory Group, and Truist Financial Co..
View the latest analyst ratings for OLPX.

What is the current price target for Olaplex?

0 Wall Street analysts have set twelve-month price targets for Olaplex in the last year. Their average twelve-month price target is $2.30, suggesting a possible upside of 27.1%. Truist Financial Co. has the highest price target set, predicting OLPX will reach $3.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $1.50 for Olaplex in the next year.
View the latest price targets for OLPX.

What is the current consensus analyst rating for Olaplex?

Olaplex currently has 4 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in OLPX, but not buy more shares or sell existing shares.
View the latest ratings for OLPX.

What other companies compete with Olaplex?

How do I contact Olaplex's investor relations team?

Olaplex's physical mailing address is 1187 COAST VILLAGE ROAD SUITE 1-520, SANTA BARBARA CA, 93108. The company's listed phone number is 310-691-0776 and its investor relations email address is [email protected]. The official website for Olaplex is www.olaplex.com. Learn More about contacing Olaplex investor relations.